Background: Antibiotic resistance is growing in low-income countries (LICs). Children in LICs are particularly at risk. Information on antibiotic consumption is needed to control the development and spread of resistant bacteria.
Introduction
Antibiotic resistance is growing rapidly in both high-and lowincome countries (LICs). 1 The WHO has deemed this issue a 'global health security threat' and recently created a global action plan to tackle the problem. 1, 2 LICs are particularly important targets in this global fight as they are home to a number of risk factors for the development and spread of resistance including: substandard hygiene and overcrowding, misuse of antibiotics, over-the-counter and parallel market access, and counterfeit or poor-quality drugs. 3, 4 Increasing antibiotic consumption in LICs amplifies these risk factors 5 and the recent worldwide spread of carbapenem resistance NDM-1-producing Enterobacteriaceae highlights the potential for resistance development and spread in LICs. 6 LICs are also home to a high burden of infectious and bacterial disease particularly among children. 7, 8 Bacterial infections, including sepsis, pneumonia, tetanus, meningitis and diarrhoea, are the leading cause of these severe infections.
9,10 Increased childhood morbidity and mortality due to resistance threatens to reverse the gains made in these areas in recent years and jeopardizes the objectives for childhood mortality established by the Sustainable Development Goals. 11 The increased economic burden of resistance also poses a threat to the budgets of overburdened healthcare systems. 12, 13 Misuse and overuse of antibiotics is a major contributor to antibiotic resistance. Several targets exist to reduce inappropriate consumption including: the general population, antibiotic providers, hospitals and governmental policies.
14 Prioritizing these targets requires reliable data on frequency and amount of antibiotic use, patient and provider knowledge, drug source and quality, healthcare-seeking behaviour, and reasons for antibiotic use. This information is also important for implementation of a broader strategy to maximize the benefits of antibiotics by reducing resistance, while increasing access in LICs. 15, 16 In LICs, these data can be unreliable or non-existent. Furthermore, gathering comprehensive information is complicated by possible non-prescribed and parallel market sources of antibiotics available in many LICs, which can represent up to 100% of consumption among certain populations. 3, 4 These data are particularly sparse in countries from sub-Saharan Africa, which is home to 26 of the World Bank's 31 LICs. 17 Methods adapted to these contexts and capable of accounting for all types of non-prescribed consumption must therefore be used in order to explore this issue in LICs. 18 To measure antibiotic consumption and related factors in LICs, we undertook community surveys among children in both Madagascar, an LIC, and Senegal, a middle -low income country. 17 In 2010, under-5 mortality rates were estimated to be 67 per 1000 live births in Senegal and 63 per 1000 live births in Madagascar. Of these deaths, 15.9% and 18.3% were due to pneumonia and 8.6% and 10.4% to diarrhoea in each country, respectively. 7 While reliable data on the burden of resistance are rare, high rates of bloodstream infections due to ESBL-producing Enterobacteriaceae have been reported in Senegal among children admitted to a paediatric hospital. 19 In Madagascar, high rates of colonization with ESBL-producing bacteria have been found both among children admitted to a paediatric hospital and pregnant women. 20, 21 The objectives of the survey included: estimating the proportion of children under 2 in the study population with at least one episode of consumption in the last 3 months, determining factors associated with antibiotic consumption, and comparing consumption patterns across countries. To our knowledge, no studies have been published on antibiotic consumption among children in these countries. The age range and study sites were selected in an effort to harmonize results with the BIRDY programme, which studies antibiotic resistance among children under 2 in LICs including Madagascar and Senegal. 
Methods

Ethics
Survey population
A cross-sectional population-based survey was carried out between November 2014 and February 2015 in Madagascar and from April to July 2015 in Senegal. The study population in Madagascar included children under 2 living in the 2nd, 3rd and 5th districts of the urban capital city Antananarivo (total population: 1 168 898) and those living in the semi-rural city of Moramanga (total population: 46 393). In Senegal the study population included children under 2 living in Guediawaye (total population: 329 659), an urban suburb of Dakar. To be included in the study, the household contacted should have been considered the primary residence for the child and consent was required from an adult family member or caregiver who had knowledge of the child's medical history.
The study population of children under 2 in each site was estimated at 23433, 1523 and 15750 for Antananarivo, Moramanga and Guediawaye, respectively.
Household selection
A two-stage cluster survey was undertaken using compact segment sampling. 22 First, 30 clusters in each study site were selected from the study zones with probability proportional to size (PPS) methods using national census or demographic survey data. The use of 30 clusters was considered sufficient to control for anticipated between-cluster variability. 23 A cluster was defined as the smallest administrative district in both Madagascar and Senegal. The average total populations of the clusters were 7162, 3569 and 4411 for Antananarivo, Moramanga and Guediawaye, respectively. Clusters were divided into smaller equal-sized geographic units (segments), each of which contained 14 children. These segments were enumerated and one segment per cluster was selected at random using a random number table. Once a segment was selected, all houses/children in the segment were solicited to participate (see Figure 1 ). In the case of non-respondent households, one revisit was scheduled during the week and a second revisit during the weekend if necessary before considering the house unreachable. No attempt was made to replace non-respondent households.
Study size
A sample size of 400 children in each site was calculated based on an estimated 40% antibiotic use in the previous 3 months, a desired precision of 10% and a design effect of 4. The design effect is a measure of the additional variability resulting from cluster sampling techniques.
Data gathering
Data were gathered from the child's parent or other caregiver via face-toface interviews by trained field workers. Field workers used questionnaires and gathered data including sociodemographic variables, the health history of the child and the child's antibiotic consumption in the previous 3 months. In Madagascar the questionnaire was translated into Malgash by translation experts from the Institut Pasteur, Antananarivo and field tested prior to use (see the Supplementary data available at JAC Online). In Senegal the original French version was used with oral translations into Wolof agreed upon between study field workers and supervisors, and field tested prior to use. To reduce memory bias, visual aids of commonly used paediatric antibiotics as well as a locally adapted calendar were presented. Respondents were also asked to show field workers any available prescriptions, antibiotics or antibiotic packaging remaining from consumption episodes. Adult respondents in Senegal were asked additional questions regarding their own antibiotic use in the previous year and healthcareseeking behaviour for themselves and the child.
Up-to-date vaccination was defined based on local schedules, and newborns under 2.2 kg were considered underweight.
Healthcare structures and pharmacies
A mapping of healthcare structures and pharmacies located in the study areas was performed for Moramanga and Guediawaye. For Antananarivo, these data were based on pharmacy lists from the Agence du Médicament de Madagascar and data from city records.
Statistical analysis
Statistical analyses were undertaken with Stata 11.0 (StataCorp, College Station, TX, USA). Population estimates including CIs were calculated for the proportion of children with any medication use, any antibiotic use or any antibiotic use without a prescription in the last 3 months.
A community survey of antibiotic consumption among children in Madagascar and Senegal JAC Pearson's x 2 test and Wald's test were used to compare categorical and continuous variables, respectively. An exploratory logistic regression was used to determine variables associated with any consumption of antibiotics in the last 3 months (consumption in last 3 months versus none). For multivariate analysis, variables associated with the outcome of interest in the univariate analysis (at the P, 0.25 level) were included and a stepwise descending procedure was used to obtain a final logistic regression model. Pooled multivariate analyses were adjusted for study site. Significance for multivariate analysis was set at P¼0.05.
To take into account within-household correlation among households with multiple children, a multi-level logistic analysis was also performed. The svy command was used where appropriate to take into account the survey design.
Results
Sociodemographic characteristics by site
In total, 394 children were recruited in Antananarivo, 502 in Moramanga and 505 in Guediawaye. Refusals to participate were rare across sites with 23 households (1%) refusing to participate in Moramanga and 17 (,1%) and 6 (,1%) households refusing in Antananarivo and Guediawaye, respectively. No information on the presence of children under 2 in these houses or the reasons for non-participation was available. Sociodemographic characteristics for the sample populations can be seen in Table 1 . Mothers' education differed, with lower levels of education in Guediawaye. Unemployment among mothers was also different, with 52.9%, 64.6% and 76.9% unemployed at visit in Antananarivo, Moramanga and Guediawaye, respectively. Access to electricity was higher in Guediawaye (98.8%), as compared with Antananarivo (84.7%) and Moramanga (80.2%). Access to flushing toilets also differed between sites, ranging from 4.2% in Moramanga, to 6.9% in Antananarivo and 19.6% in Guediawaye. Overall, households in Senegal included more people than in Madagascar, but density per room was greater in Antananarivo (2.9 persons per room) than in Moramanga (2.6) and Guediawaye (2.5).
Children's characteristics did not show significant overall differences between sites for baby age, sex, malnutrition, premature birth or underweight births (Table 2 ). Significant overall differences were found for up-to-date vaccination at 90.5%, 71.6% and 67.6% in Guediawaye, Moramanga and Antananarivo, respectively.
Antibiotic consumption
Levels of antibiotic consumption in the last 3 months were 37.2% (95% CI 33.4% -41.2%) in Guediawaye, 29.3% (95% CI 25.0% -34.1%) in Antananarivo and 24.6% (95% CI 20.6% -29.1%) in Moramanga (Table 3 ). These differences were statistically significant overall (P, 0.01).
Non-prescription use of antibiotic was not significantly different among the three study sites at 7.8% (95% CI 4.2% -14.3%) in Antananarivo, 13.0% (95% CI 10.3% -16.3%) in Moramanga and 8.0% (95% CI 4.2% -14.7%) in Guediawaye (P ¼ 0.66).
While most antibiotics were taken for the full length of the treatment in Moramanga (75.2%) and in Antananarivo (83.7%), only 52.3% of antibiotics were correctly taken in Guediawaye.
In our sample only 6%, 5% and 2% of the sample had multiple episodes of antibiotic consumption in the previous 3 months in Antananarivo, Guediawaye and Moramanga, respectively.
The majority of antibiotics were recommended by a doctor or a nurse (regardless of the presence of a prescription) in Antananarivo (95.7%) and Guediawaye (94.4%) ( Table 4 ). In Guediawaye, a few antibiotics were recommended by the pharmacist directly (5.1%), sometimes followed by purchase without prescription. The person recommending antibiotic use was heterogeneous in Moramanga, and included 11% of antibiotics advised by a traditional healer and 2.9% by a midwife. Absence of advisor or self-advising was
Limite Fokontany 2é arronássement 3é arronássement 5é arronássement Padget et al. A community survey of antibiotic consumption among children in Madagascar and Senegal JAC reported in Moramanga (6.6%) and Antananarivo (2.0%), but not Guediawaye. For all sites, the main symptom group leading to antibiotic consumption was respiratory -ear/nose/throat symptoms, representing 60.7% of consumption episodes in Antananarivo, 68.4% in Moramanga and 38.3% in Guediawaye. The second most frequent group of symptoms reported in Antananarivo and Moramanga were digestive (25.2% and 14.3%, respectively). These symptoms accounted for 10.7% of antibiotics in Guediawaye. Cutaneous symptoms and 'other' symptoms, not including respiratory, cutaneous, digestive or ear/nose/throat symptoms, represented 12.6% and 17.8% of episodes in Senegal, respectively.
The most commonly used antibiotics were penicillins (53.5%, 66.7% and 52.8% for Antananarivo, Moramanga and Guediawaye, respectively), including mainly amoxicillin (Figure 2 ). Other antibiotics commonly used in the three study sites were metronidazole and co-trimoxazole. Cephalosporins represented 15.9% of antibiotics consumed in Guediawaye 3.5% in Antananarivo and 4.5% in Moramanga. A small proportion of quinolones was found in Moramanga (1.5%) and in Guediawaye (0.9%).
Most antibiotics were bought from private pharmacies (89.4%, 73.5% and 78.5% in Antananarivo, Moramanga and Guediawaye, respectively). In Senegal the remaining antibiotics were obtained from hospitals and public health facilities. In Madagascar, purchase from the doctor directly accounted for 7.0% and 7.4% of antibiotics in Antananarivo and Moramanga, respectively. Other sources identified in Moramanga included: depots (0.7%), general stores (4.4%) and traditional healers (1.5%). Among children with at least one antibiotic. c Antibiotic consumption episodes used at the denominator for this variable rather than the survey population (Antananarivo¼142, Moramanga¼134 and Guediawaye¼214).
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Factors associated with antibiotic consumption
Factors associated with antibiotic consumption in univariate analysis using data pooled across sites included housing and baby age (Table 5) . Living in a house in a compound and living in a room in a house shared with other households was associated with lower antibiotic consumption compared with living in an individual house. Age above 6 months was also associated with greater antibiotic consumption compared with the 0 -6 month group.
While overall P values showed significance for housing, individuallevel comparisons were not significant. Similar results were obtained when analysis was restricted to babies older than 3 months old (data not shown).
Following a stepwise selection and adjusting for site, two factors remained significantly associated with higher antibiotic consumption in the last 3 months: living in houses without flushing toilets (OR 1.4, 95% CI 1.0 -1.9) and baby age (OR 1.8, 95% CI 1.2 -2.6 for children 6 -,12 months; OR 1.8, 95% CI 1.1 -2.8 for children 12 -,18 months; OR 1.5, 95% CI 0.9 -2.2 for children 18 -24 months versus children 0 -,6 months). Neither vaccination status nor any other child health characteristics were associated with antibiotic consumption.
In site-specific analyses, three factors were independently associated with antibiotic consumption in the last 3 months in Guediawaye: parent antibiotic consumption in the last year (OR 2.5, 95% CI 1.1-5.8), systematic use of health structures in case of fever, diarrhoea or cough (OR 5.4, 95% CI 2.1-13.4) and nonflushing toilets (OR 1.8, 95% CI 1.2 -2.6). Analyses of combined Madagascar site data found that child ages of 6 -,12 months (OR 3.8, 95% CI 2.4 -6.1), 12 -,18 months (OR 3.4, 95% CI 2.0-5.8) and 18-24 months (OR 2.6, 95% CI 1.3-5.3) were associated with higher antibiotic consumption as compared with the 0 -,6 month group. The number of rooms in a household was also significant with higher antibiotic usage among children living in households with two rooms (OR 1.8, 95% CI 1.2-2.8) or three or more rooms (OR 1.5, 95% CI 1.0-2.3) versus those with one room. Information on parent antibiotic consumption and systematic use of health structures were not available in Antananarivo and Moramanga.
Due to the limited number of households with multiple children, results from multi-level logistic analyses were similar to those obtained from the simple model (results not shown).
Antibiotic consumption and structural factors
Among our three sites, a higher density of public health structures was associated with lower consumption levels (Figure 3a) . Conversely, a higher density of private pharmacies in the study area was associated with a higher level of antibiotic consumption (Figure 3b ).
Discussion
To our knowledge, the results of our study are the first comprehensive estimates of antibiotic consumption among children in Madagascar and Senegal and add important data to the antibiotic consumption literature in LICs for which few quality data exist. The collection of factors related to antibiotic use is also important in order to understand consumption and develop any necessary public health or surveillance methods. Substantial levels of consumption in the last 3 months were found, particularly in Senegal.
The observed proportions were lower than results from community surveys in other LICs from South-East Asia. 24 -26 In addition to real differences in antibiotic consumption, our methodology and use of various study tools may have reduced selection bias and misclassification of non-antibiotic medication, leading to increased consumption measures in other studies. The observed proportions more closely matched those among children in developed countries, but remain elevated. 27 -29 A community survey of antibiotic consumption among children in Madagascar and Senegal
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Data from Madagascar and Senegal show no peak in influenza cases during the study recall period (surveillance data from Malagasy Health Ministry). 30 Influenza has been found to be a main driver of antibiotic consumption in other countries and the observed consumption rates may thus reflect a baseline measure. 31 The majority of antibiotic consumption was prescribed for children with respiratory and ear/nose/throat symptoms in all sites. These symptoms are related to upper respiratory tract infections, which are often caused by viruses and for which antibiotics are not recommended. 32 Use of microbiological test results to guide antibiotic prescribing is rare in LICs. However, without proper diagnostic testing, determining the causative agent of an infection is difficult and prescribing an antibiotic may be more likely. Development and use of adapted diagnostic tools could help improve prescribing and avoid unnecessary use. In Senegal a number of symptoms classified as 'other' included a variety of non-infectious diseases for which antibiotics are inappropriate.
In pooled multivariate exploratory analyses adjusted on site only two variables remained significant. Non-flush toilets may reflect a lower socioeconomic status or play a role in disease spread, although no difference was noted in symptoms according to toilet type. Age .6 months was also associated with increased antibiotic consumption. No difference in symptom profiles was found between age groups, suggesting increased infectious episodes rather than changing disease patterns.
Interestingly, vaccination coverage was not associated with a reduction in antibiotic use in pooled analyses. Increased vaccination has been proposed as a potential means to reduce the use of antibiotics. The adjusted OR (aOR) was adjusted for study site.
The higher antibiotic consumption in Senegal compared with Madagascar may be due to a higher overall healthcare use and use of medication, which can be seen in the significantly higher use of any medication in the last 3 months among Senegalese children. A higher overall socioeconomic status in Senegal might also translate into greater healthcare access and antibiotic consumption.
Recent analyses show that the countries with the highest growth of antibiotic consumption were middle-income countries with growing economies. 5 The difference in consumption between Senegal, a lower-middle income country, and Madagascar, an LIC, supports this finding.
Respective national health policies in each country may also play a role in consumption differences. In 2013, a Universal Health Coverage law was launched in Senegal under which healthcare for children under 5, including a number of antibiotics, became free in public health facilities. In Madagascar, evaluation and follow-up of children is free in public health centres. However, any medication, including antibiotics, must be paid for, which can create barriers to access for the poorest families. 33 Increases in antibiotic usage, both appropriate and inappropriate, have been observed in patients provided with free healthcare compared with controls in randomized and observational studies. 34, 35 Interestingly, the number of public healthcare centres per capita was inversely correlated with antibiotic consumption. The Senegalese study population had fewer public health centres per capita. Additionally, 12 of the 13 healthcare centres in Guediawaye were low-level health structures staffed by nurses or other non-doctor health personnel. All public healthcare structures in Madagascar, on the other hand, were staffed with doctors. The relative scarcity of health structures may translate into shorter consultation times. These shorter consultations combined with undertrained staff and free antibiotics found in Senegal may largely contribute to the higher rates of medication and antibiotics observed in that country.
A higher number of pharmacies per capita was also correlated with increased antibiotic consumption in the three sites. This could be due to a greater availability of drugs overall and greater proximity to the families, resulting in facilitated access to antibiotics. Hypotheses surrounding the access to healthcare and pharmacy density remain speculative, however, and their contribution to antibiotic consumption is unknown.
Antibiotic consumption patterns of children enrolled in the BIRDY cohort study provide insight into the role of prescriber training. Enrolled children benefit from free medical care and medication, including medical evaluations by trained paediatricians. They are similar socioeconomically to the children included in our survey and live near survey study zones. Children in the cohort, however, showed antibiotic consumption proportions in the last 3 months of just under 20% in both Antananarivo and Moramanga during the same study period (B. T. Huynh, M. Padget, P. Herindrainy, P. Piola, E. Delarocque-Astagneau and D. Guillemot, unpublished data; http://www.birdyprogram.org/). In this case, access to free healthcare and antibiotics did not result in higher consumption, highlighting the role of prescriber training.
Non-prescription use in both countries was lower than two other studies in LIC settings. 26, 36 These relatively low proportions may be due to parents and antibiotic distributors being particularly cautious about providing non-prescribed medication to small children.
In Moramanga, slightly higher proportions of non-prescribed antibiotics were observed. A higher heterogeneity of antibiotic advisor and place of purchase, common in rural LIC settings, was also observed although no association with non-prescribed consumption was tested statistically.
The large majority of antibiotics in all sites were obtained in pharmacies and recommended by a doctor. These findings correlate with the relatively low levels of non-prescription use. In Senegal over 90% of respondents suggested they would always seek a medical consultation if a child had cough, fever or diarrhoea, while only 57% would do the same for themselves. These are positive findings in terms of surveillance and public health interventions. With low use of alternative antibiotic sources and few non-prescribed episodes, antibiotic surveillance for child use focused principally on pharmacies may be appropriate and interventions aimed at doctors might be effective in reducing unnecessary use.
Non-compliance with antibiotic duration may be a risk factor for the development and transmission of resistance and the low compliance seen in Guediawaye is a concern. This may be attributable to the fact that many prescriptions were coming from staff who did not properly explain the importance of finishing the antibiotic course due to lack of training or time constraints. A community survey of antibiotic consumption among children in Madagascar and Senegal
Some limitations are associated with the cross-sectional nature of this study. Recall biases could have been an issue leading to unreported episodes of antibiotic consumption in the last 3 months, leading to lower observed rates. This may have been a problem specifically when multiple consumption episodes occurred in the study time-frame. Episodes outside the study time-frame may also have been counted. Desirability bias may have played a role in the low rates of non-prescribed antibiotic consumption as participants may not want to report nonprescription use. We tried to control for these biases with the use of study tools such as the calendar as well as questionnaire design and question placement. Verification of antibiotic packaging and prescriptions consistently corresponded with verbal responses, confirming our confidence in the data collected.
In addition to important information on a high-risk population, the results from these surveys are useful for comparing across countries and shaping specific policy measures. While these results may not be generalized to other LICs due to the heterogeneity among these countries, they may be generalized within countries to areas with similar population characteristics.
The presence of the BIRDY study is valuable as consumption data from each site can be compared with local community resistance profiles and inform a larger narrative on antibiotic resistance in LICs. The widespread use of third-generation cephalosporins in Senegal is of special interest as these drugs are related to the presence of ESBLs and high proportions of ESBL-positive bloodstream infections have recently been reported in this country. 19 
Conclusions
These data are crucial for the implementation of programmes aimed at optimizing antibiotic consumption. Our results show elevated levels of antibiotic consumption, but often for symptoms suggestive of viral infection. While any unnecessary use must be reduced, there is no guarantee that all children needing antibiotics are getting them. LICs must be careful to balance restriction and access in the context of antibiotic resistance. 15 Country-level factors such as density of healthcare facilities, national antibiotic payment programmes and prescriber training were important in driving antibiotic consumption and must be taken into account when developing strategies to optimize antibiotic consumption in LICs. Similar investigations could be useful in other LICs where consumption data are lacking and risk factors exist for the development and spread of antibiotic resistance.
